Artigo Acesso aberto Revisado por pares

Atovaquone Compared with Dapsone for the Prevention of Pneumocystis carinii Pneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both

1998; Massachusetts Medical Society; Volume: 339; Issue: 26 Linguagem: Inglês

10.1056/nejm199812243392604

ISSN

1533-4406

Autores

Wafaa El‐Sadr, Robert L. Murphy, Teresa McCabe Yurik, Roberta Luskin‐Hawk, Tony Cheung, Henry H. Balfour, Robert H.K. Eng, Thomas M. Hooton, Thomas M. Kerkering, Malte Schütz, Charles van der Horst, Richard Hafner,

Tópico(s)

Tuberculosis Research and Epidemiology

Resumo

Although trimethoprim–sulfamethoxazole is the drug of choice for the prevention of Pneumocystis carinii pneumonia, many patients cannot tolerate it and must switch to an alternative agent.

Referência(s)